Charcot-Marie-Tooth disease axonal type 2T (CMT2T) is a rare inherited nerve disease that mainly damages the long “wires” of the peripheral nerves, called axons. These nerves carry signals from the brain and spinal cord to the muscles and bring back feeling from the skin. In CMT2T, the axons slowly stop working, especially in the nerves to the feet and lower legs. This leads to weak muscles, thinner legs, problems with walking, and reduced feeling in the feet and later in the hands. CMT2T usually starts in adult life and gets worse slowly over many years. It is autosomal recessive, which means a person becomes affected when they receives one changed copy of a specific gene from each parent. GARD Information Center+2MalaCards+2
Charcot-Marie-Tooth Disease Axonal Type 2T (CMT2T) is a rare genetic nerve disease. It mainly damages the long “wires” of the peripheral nerves (the axons). These nerves carry signals from the spinal cord to the muscles and bring back sensations like touch and pain from the skin. In CMT2T, the axons slowly get weaker and thinner, so the nerve signals become weak or delayed. Over many years this causes muscle weakness, wasting, and loss of feeling, especially in the feet and hands.GARD Information Center+2ZFIN+2
CMT2T is usually autosomal recessive. That means a person inherits a faulty copy of the gene from both parents. The main gene linked to CMT2T is called MME, which codes for a protein (membrane metalloendopeptidase) important in nerve function. When this protein does not work properly, axons slowly degenerate and cannot carry signals correctly.ZFIN+1
In CMT2T, the main gene that is known to be involved is called MME (membrane metallo-endopeptidase). Changes (mutations) in both copies of the MME gene lead to loss or reduction of the normal protein, also known as neprilysin. This protein helps break down certain small signaling molecules around nerves. When the protein does not work well, waste products can build up and axons can slowly become sick and die, causing the neuropathy. National Organization for Rare Disorders+2Monarch Initiative+2
Other names
Doctors and researchers use several different names for Charcot-Marie-Tooth disease axonal type 2T. All of these refer to the same or very closely related condition: MalaCards+2Monarch Initiative+2
Charcot-Marie-Tooth disease, axonal, type 2T
CMT2T
Autosomal recessive axonal Charcot-Marie-Tooth disease type 2T
Charcot-Marie-Tooth neuropathy type 2T
Charcot-Marie-Tooth neuropathy, axonal type 2T
These names remind us that this is (1) a Charcot-Marie-Tooth condition, (2) mainly damages the axon part of the nerve, and (3) is a type 2 (axonal) form with a specific genetic cause. NCBI+1
Types (clinical patterns)
There is no official worldwide system of “subtypes” only inside CMT2T. However, doctors notice that people with CMT2T can show slightly different clinical patterns. These are not strict separate diseases, but they help to understand how the condition may look in real life. GARD Information Center+2MalaCards+2
Classic adult-onset CMT2T pattern
In many people, symptoms start in mid-adult life, often between the 30s and 50s. The first signs are weakness in the lower legs, difficulty walking long distances, and reduced ankle reflexes. Feeling in the feet becomes slowly dull over many years. This is the most typical picture described in rare disease databases. GARD Information Center+1Late-adult mild pattern
Some individuals may not notice serious problems until later adulthood. They can still walk independently but feel easily tired in the legs and have mild numbness in the feet. The disease course is very slow, and disability remains limited for a long time. GARD Information Center+1Motor-predominant pattern
In a few patients, muscle weakness and wasting in the legs are more prominent than sensory changes. They mainly complain of foot drop, tripping, and difficulty climbing stairs, while loss of feeling may be mild. This still fits CMT2T because motor and sensory axons can be affected to different degrees. Muscular Dystrophy Association+1Sensory-motor balanced pattern
Many patients have both weakness and sensory loss in a similar degree. They feel numbness, tingling, and burning in the feet, together with visible thinning of the lower-leg muscles. Reflexes are reduced or absent at the ankles, and balance may be poor in the dark. GARD Information Center+2Muscular Dystrophy Association+2Upper-limb-involvement pattern
In later stages, some people develop weakness and sensory loss in the hands. They may have trouble opening jars, buttoning clothes, or writing. This pattern is still part of CMT2T and usually appears after many years of leg involvement. GARD Information Center+1
Causes
Remember: the main cause of CMT2T is genetic. Many of the points below describe different aspects of that genetic cause and factors that can influence how the disease shows itself.
Pathogenic mutations in the MME gene
The core cause of CMT2T is a disease-causing change (mutation) in both copies of the MME gene. This gene gives instructions to make the neprilysin protein. When the gene is changed, the protein cannot work properly, leading to slowly progressive axonal damage in motor and sensory nerves. National Organization for Rare Disorders+2Monarch Initiative+2Autosomal recessive inheritance
CMT2T usually follows an autosomal recessive pattern. A person is affected when they inherit one non-working copy of the MME gene from each parent. The parents usually have one normal and one changed copy and are typically healthy “carriers”. GARD Information Center+2Monarch Initiative+2Homozygous MME mutations
In some families, both copies of the MME gene have the exact same mutation (homozygous). This situation often leads to typical CMT2T with adult-onset, slowly progressive sensorimotor neuropathy. search.thegencc.org+1Compound heterozygous MME mutations
In other patients, each copy of the MME gene has a different disease-causing mutation (compound heterozygosity). Together these two different errors still prevent normal protein function and cause the same clinical picture of CMT2T. Monarch Initiative+1Loss of neprilysin enzyme activity
MME encodes neprilysin, an enzyme that breaks down small signaling peptides in the nervous system. When mutations reduce its activity, these peptides may build up around the axons and disturb their function, contributing to axonal degeneration. National Organization for Rare Disorders+1Disturbed axonal maintenance
Peripheral nerve axons need a stable environment and good support from Schwann cells and surrounding tissues. Abnormal neprilysin activity can change this environment, which may weaken axons over many years and lead to the length-dependent neuropathy seen in CMT2T. NCBI+1Length-dependent vulnerability of nerves
The longest nerves, such as those running from the spinal cord to the feet, are more fragile when axonal support is not perfect. Because of this length-dependent vulnerability, symptoms of CMT2T first appear in the feet and lower legs. NCBI+2Europe PMC+2Family consanguinity (related parents)
When parents are related (for example, cousins), they have a higher chance of carrying the same rare MME mutation. This increases the risk that their children will inherit two changed copies and develop CMT2T. This is a general rule for many autosomal recessive diseases. JCN+1De novo mutations (rare)
Very rarely, a new mutation can appear in the MME gene in one generation. If such a mutation is then passed on and combined with another pathogenic variant, a child may develop CMT2T even if there is no family history. JCN+1Genetic background and modifier genes
Other genes may slightly change how severe the neuropathy becomes or at what age it starts. These “modifier genes” do not cause CMT2T by themselves but may make the course milder or more severe. ScienceDirect+1Age-related axonal wear
Because CMT2T often starts in adulthood, normal age-related wear on nerves may interact with the underlying genetic defect. Over time, the combination can lead to obvious symptoms, even if the person felt normal when young. NCBI+1Metabolic stress on nerves
Conditions like diabetes, high blood sugar, or high cholesterol can damage peripheral nerves on their own. In a person who already has CMT2T, such metabolic problems may worsen neuropathy. They do not cause the genetic disease but can add extra stress to already fragile axons. arupconsult.com+1Nutritional deficiencies
Lack of certain vitamins (for example, vitamin B12) can damage nerves. In someone with CMT2T, poor nutrition may make symptoms worse or bring them out earlier, although it is not the original cause of the condition. arupconsult.com+1Toxic nerve exposures
Some medicines and toxins (such as certain chemotherapy drugs or heavy metals) can injure peripheral nerves. In people carrying MME mutations, these exposures can further harm nerves and increase weakness or numbness. arupconsult.com+1Repeated mechanical stress on feet and legs
Long-term physical overload, such as heavy manual work or intense sports without rest, does not cause CMT2T but can aggravate pain and fatigue in already weak leg muscles, making symptoms more noticeable. NCBI+1Chronic inflammation around nerves
If a person with CMT2T develops another illness that inflames nerves (for example, autoimmune neuropathy), this can worsen axonal loss. Here the genetic disease and acquired inflammation act together. arupconsult.com+1Hormonal or thyroid problems
Thyroid disease and other hormonal issues can affect nerve function. When they occur in someone with CMT2T, they may intensify neuropathy or slow recovery after nerve stress. arupconsult.com+1Lifestyle factors (smoking, alcohol misuse)
Smoking and heavy alcohol use can harm blood vessels and nerves. These habits can make symptoms of CMT2T worse, especially pain, numbness, and balance problems, even though they are not primary genetic causes. arupconsult.com+1Co-existing neuropathies
A person with CMT2T might also develop another neuropathy, such as immune-mediated or diabetic neuropathy. The combined effect can lead to more severe disability than CMT2T alone. arupconsult.com+1Delayed diagnosis and lack of support
If CMT2T is not recognized early, there may be no advice on foot care, physical therapy, or fall prevention. This delay does not cause the genetic problem, but it can lead to avoidable complications such as contractures and falls, which worsen overall function. NCBI+1
Symptoms
Slowly progressive weakness in the feet and lower legs
The most common early symptom is slowly increasing weakness in the muscles that lift the foot and ankle. People may notice difficulty running, climbing stairs, or walking uphill. This happens because the long motor axons to these muscles are damaged first. GARD Information Center+1Muscle wasting in the lower legs
Over time, the muscles in the lower legs become thinner and smaller, giving a “stork-leg” look. The body cannot keep the muscles healthy because the nerve supply is reduced. GARD Information Center+2Muscular Dystrophy Association+2Foot drop and tripping
Weakness in the muscles that lift the toes can cause the front of the foot to drag on the ground. This is called foot drop. People may trip more often, especially on uneven ground or when they are tired. Muscular Dystrophy Association+1Gait disturbance
Many patients develop a “steppage gait.” They lift their knees higher than normal so that their toes do not catch on the floor. Walking may become slower and less steady, but most patients remain able to walk for many years. GARD Information Center+2Muscular Dystrophy Association+2Numbness in the feet
Loss of normal feeling (touch, vibration, and position sense) often starts in the toes and feet. People may feel like they are “wearing socks” even when barefoot. This is due to damage of sensory axons. GARD Information Center+2NCBI+2Tingling or burning sensations
Some patients feel tingling, pins-and-needles, or burning pain in the feet. These uncomfortable sensations come from irritated or mis-firing sensory nerves. NCBI+2Muscular Dystrophy Association+2Reduced or absent ankle reflexes
When the doctor taps the Achilles tendon at the back of the ankle, the normal kick-back may be very weak or absent. This loss of deep tendon reflexes is a common sign in CMT2T and other CMT types. GARD Information Center+2Muscular Dystrophy Association+2Balance problems, especially in the dark
Because the feet lose position sense, it is harder for the brain to know where the body is in space. Standing still with eyes closed can be difficult and may cause swaying or near-falls. NCBI+2Muscular Dystrophy Association+2Mild weakness in the hands (later)
After years of leg symptoms, some people develop weakness in the small muscles of the hands. They may drop objects, find it hard to button clothes, or have trouble with fine tasks such as writing or sewing. GARD Information Center+2Muscular Dystrophy Association+2Mild sensory loss in the hands
Numbness or reduced feeling can also affect the fingers and hands, but usually after the feet have been involved for a long time. This reflects the “length-dependent” spread of the neuropathy. GARD Information Center+2NCBI+2Foot deformities
Over years, imbalance between strong and weak muscles can create high arches (pes cavus), curled toes (hammer toes), or other foot shapes. These deformities may make shoe fitting and walking more difficult. NCBI+2Muscular Dystrophy Association+2Fatigue in legs after walking
People often report that their legs feel heavy or tired after walking short distances. Because axons are damaged, muscles need more effort for the same task, leading to early fatigue. NCBI+1Cramps or muscle tightness
Some patients experience cramps or tight feelings in the calves or feet, especially at night or after activity. This can be due to unstable nerve firing and weak muscles working harder than usual. NCBI+1Mild neuropathic pain
Although CMT is often described as “painless,” some people do feel chronic aching or burning pain in the feet and legs. This pain comes from damaged sensory nerves sending abnormal signals. arupconsult.com+1Psychological impact and reduced confidence
Long-term problems with walking, balance, and hand function can affect mood and self-confidence. People may feel anxious about falling or embarrassed about their walking pattern. This emotional burden is part of living with a chronic neuropathy. arupconsult.com+1
Diagnostic tests
Doctors use a combination of clinical examination, electrical studies, genetic tests, and sometimes imaging or tissue tests to diagnose CMT2T. The goal is to confirm that there is a length-dependent axonal neuropathy and to find the MME gene mutation. NCBI+2arupconsult.com+2
Physical examination tests
General neurologic examination
The neurologist checks mental status, cranial nerves, strength, feeling, reflexes, and coordination. In CMT2T, the main findings are distal weakness, sensory loss in a stocking pattern, and reduced ankle reflexes, with normal brain and spinal cord signs. NCBI+1Inspection of muscles and feet
The doctor looks for muscle wasting in the lower legs and feet, high arches, hammer toes, and thin calves. These visible changes support a chronic peripheral neuropathy with long-standing axonal damage. NCBI+2Muscular Dystrophy Association+2Reflex examination
Deep tendon reflexes are tested with a small hammer at the knees and ankles. In CMT2T, ankle reflexes are often weak or absent, while knee reflexes may be reduced or preserved until later. This pattern fits a length-dependent neuropathy. GARD Information Center+2Muscular Dystrophy Association+2Gait and balance assessment
The doctor observes how the person walks, turns, and stands. They look for steppage gait, poor heel walking, and difficulty standing with feet together and eyes closed (indicating balance problems due to sensory loss). NCBI+2Muscular Dystrophy Association+2
Manual bedside tests
Manual muscle strength testing (MRC scale)
The examiner resists the patient’s movements and grades strength on a standard scale (usually 0–5). In CMT2T, weakness is worst in ankle dorsiflexion and toe extension at first, and later in hand muscles. NCBI+2Muscular Dystrophy Association+2Romberg test
The patient stands with feet together and then closes their eyes. If they sway or lose balance more with eyes closed, it suggests loss of position sense from the feet, which is common in CMT-type neuropathies. NCBI+1Heel-walk and toe-walk test
The person is asked to walk on their heels and then on their toes. Difficulty heel-walking is a sensitive sign of weakness in the muscles that lift the feet, a frequent early sign in CMT2 and other distal neuropathies. Muscular Dystrophy Association+2NCBI+2Hand function and fine-motor tests
Simple bedside tasks, such as buttoning a shirt, writing a sentence, or manipulating small objects, help assess hand strength and coordination. In later CMT2T, these tasks may become slow or clumsy. NCBI+2Muscular Dystrophy Association+2
Laboratory and pathological tests
Basic blood tests to exclude other causes
Blood tests (for example, blood sugar, vitamin B12, thyroid function, kidney and liver tests) are usually done to rule out common acquired causes of neuropathy. A normal result supports the idea of a hereditary neuropathy such as CMT2T. arupconsult.com+1Serum creatine kinase (CK)
CK measures muscle breakdown. In CMT, CK is often normal or only mildly raised, which helps distinguish CMT from primary muscle diseases that cause much higher CK levels. NCBI+1Genetic testing – targeted MME sequencing
If CMT2T is suspected (for example, based on clinical features and family pattern), DNA can be tested specifically for mutations in the MME gene. Finding two pathogenic variants (one on each copy) confirms the diagnosis. search.thegencc.org+2Monarch Initiative+2Genetic testing – multi-gene neuropathy panel
Often, doctors order a panel that checks many CMT-related genes at once. This is useful because CMT is very genetically diverse, with dozens of possible genes. If the panel finds biallelic MME mutations, it points to CMT2T. JCN+2ScienceDirect+2Whole-exome or whole-genome sequencing
In complex or unclear cases, broader genetic tests that read all coding genes (exome) or the whole genome may be used. These tests can discover rare or new MME mutations and other neuropathy genes. ScienceDirect+2JCN+2Nerve biopsy (rarely needed now)
A small piece of a sensory nerve (often from the ankle area) can be removed and examined under a microscope. In axonal CMT, the biopsy shows loss of axons with some secondary changes. Today, nerve biopsy is used much less because genetic testing is safer and more precise. NCBI+2arupconsult.com+2Skin biopsy with nerve fiber analysis
A tiny skin sample can be taken from the leg, and small nerve fibers in the skin can be counted. Reduced nerve fiber density supports a diagnosis of peripheral neuropathy and may be used in research or special clinical settings. arupconsult.com+1
Electrodiagnostic tests
Nerve conduction studies (NCS)
Small electrical pulses are applied to nerves, and sensors record how fast and how strongly signals travel. In CMT2T, conduction velocities are often near normal or only mildly slow, but the size of the response (amplitude) is reduced, showing axonal loss rather than severe demyelination. Europe PMC+2NCBI+2Electromyography (EMG)
A thin needle electrode is placed into muscles to record their electrical activity. In CMT2T, EMG often shows signs of long-standing nerve loss, such as large motor units and decreased recruitment, which confirms a chronic axonal neuropathy. NCBI+2arupconsult.com+2Late response studies (F-waves and H-reflexes)
Special nerve conduction tests can look at signals traveling back and forth between the limb and spinal cord. In CMT2T, these responses may be reduced or absent in the legs, supporting the presence of a length-dependent neuropathy. NCBI+1Quantitative sensory testing (QST)
QST uses controlled stimuli (such as mild heat, cold, or vibration) to measure how sensitive the person is to different sensations. Abnormal thresholds in the feet support the clinical impression of sensory nerve damage. NCBI+1
Imaging tests
Magnetic resonance imaging (MRI) of nerves or spine
MRI is not always required but may be used to exclude other causes of leg weakness (such as spinal cord compression) and sometimes to visualize enlarged or abnormal peripheral nerves. In CMT2 and related conditions, MRI can show muscle wasting patterns and, in some centers, nerve changes on “MR neurography.” NCBI+2arupconsult.com+2
Non-Pharmacological Treatments (Therapies and Others)
Regular physiotherapy exercise
Description: A physiotherapist teaches safe stretching, strengthening and balance exercises suited to the person’s weakness level.
Purpose: To keep muscles flexible and strong, delay contractures, and reduce falls.
Mechanism: Gentle, repeated movement keeps joints moving, improves blood flow, and helps remaining nerve–muscle units work more efficiently.PMC+1Stretching of legs and feet
Description: Daily calf, hamstring, and ankle stretches done at home or with a therapist.
Purpose: To prevent tight tendons and fixed deformities that make walking harder.
Mechanism: Slow stretching lengthens muscle–tendon units and reduces stiffness caused by long-term nerve damage.Strength training with low resistance
Description: Light resistance bands or small weights targeting less-affected muscles.
Purpose: To maintain muscle bulk without over-fatiguing weak muscles.
Mechanism: Mild overload signals muscles to adapt, while careful supervision avoids damage to fragile axons.Aerobic exercise (walking, cycling, swimming)
Description: Low-impact activities, a few times per week, matched to breathing and fatigue levels.
Purpose: To improve stamina, heart health, and mood.
Mechanism: Aerobic training improves oxygen use and circulation, which may indirectly support nerve health and reduce fatigue.Ankle–foot orthoses (AFOs)
Description: Lightweight braces worn in the shoes to hold the ankle at a stable angle.
Purpose: To reduce foot drop, improve walking, and prevent trips and falls.
Mechanism: The brace mechanically lifts the toes and stabilizes the ankle, compensating for weak ankle muscles.nhs.uk+1Supportive footwear and custom insoles
Description: Shoes with firm heels, wide toe boxes, and custom insoles for high arches or flat feet.
Purpose: To protect feet, spread pressure, and reduce pain and calluses.
Mechanism: Good shoe structure and insoles realign the foot and improve weight distribution.Occupational therapy (OT)
Description: An occupational therapist teaches ways to adapt daily tasks, use special tools, and adjust the home or workplace.
Purpose: To maintain independence in dressing, writing, typing, cooking, and hobbies.
Mechanism: OT reduces the strain on weak hand and arm muscles by using ergonomic tools, splints, and task-simplifying tricks.ScienceDirect+1Hand splints and wrist supports
Description: Soft or rigid splints worn on wrists or thumbs.
Purpose: To improve grip, reduce joint strain, and help fine motor tasks like writing.
Mechanism: Splints position the joints in a more stable and energy-efficient posture, compensating for weak muscles.Balance and gait training
Description: Specific exercises such as standing on different surfaces, stepping patterns, and walking drills.
Purpose: To lower risk of falls and improve confidence walking indoors and outdoors.
Mechanism: Repetition trains the brain and remaining nerve pathways to improve coordination and automatic balance reactions.Hydrotherapy (pool exercises)
Description: Supervised exercises done in warm water.
Purpose: To move safely with less weight on joints and less risk of falling.
Mechanism: Water supports body weight and provides gentle resistance, helping weak muscles work without overload.Speech therapy
Description: Work with a speech-language therapist when speech or swallowing becomes difficult.
Purpose: To keep communication clear and prevent choking or aspiration.
Mechanism: Specific exercises strengthen facial, tongue, and swallowing muscles and teach safe eating strategies.Respiratory therapy and breathing exercises
Description: Tests and training from a respiratory therapist if breathing muscles weaken.
Purpose: To detect early breathing weakness and train more effective breathing patterns or cough.
Mechanism: Devices and exercises improve chest expansion and help clear mucus to reduce infections.Night splints and positioning
Description: Braces or cushions used during sleep to keep ankles, knees or wrists in good alignment.
Purpose: To prevent contractures and morning stiffness.
Mechanism: Steady positioning over many hours stops muscles from shortening while at rest.Pain self-management techniques
Description: Relaxation, heat/cold packs, gentle massage, and pacing of activity.
Purpose: To lessen chronic neuropathic pain and muscle cramps.
Mechanism: Non-drug methods calm overactive pain pathways and reduce muscle spasm.Psychological counseling
Description: Regular sessions with a counselor or psychologist familiar with chronic illness.
Purpose: To help cope with anxiety, low mood, and life-planning in a progressive condition.
Mechanism: Cognitive-behavioral strategies and emotional support reduce stress, which can worsen pain and fatigue.Assistive devices (canes, walkers, wheelchairs)
Description: Mobility aids chosen based on current strength and balance.
Purpose: To keep the person mobile and safe, even if leg weakness becomes severe.
Mechanism: Devices transfer some of the weight and balance work from weak muscles to the device structure.Home and workplace modifications
Description: Installing grab bars, ramps, non-slip mats, and ergonomic desks.
Purpose: To prevent falls and reduce effort during daily tasks.
Mechanism: Environmental changes remove hazards and lower the physical demand on weakened limbs.Patient and family education
Description: Clear teaching about the disease, prognosis, and realistic expectations.
Purpose: To support informed decisions, early problem-spotting, and correct use of aids.
Mechanism: Knowledge helps families recognize complications quickly and work as a team with health professionals.Support groups and rehabilitation programs
Description: Meeting others with CMT in person or online, sometimes through charities or clinics.
Purpose: To share tips, emotional support, and trusted information.
Mechanism: Social connection reduces isolation and improves adherence to exercise and treatment plans.Genetic counseling for the family
Description: Sessions with a genetics professional to discuss inheritance and testing.
Purpose: To understand risk for children and relatives and plan future pregnancies.
Mechanism: Explains autosomal-recessive inheritance and options like carrier testing and prenatal or pre-implantation testing.GARD Information Center+1
Drug Treatments
(from FDA-approved medicines mainly used for neuropathic pain or related symptoms; not specific cures for CMT2T)
Gabapentin (Neurontin, Gralise, Horizant)
Class: Antiepileptic / neuropathic pain medicine.
Use: Often used off-label to reduce nerve pain, burning, and tingling.
Typical dosing: Adults often start around 300 mg per day and slowly increase in divided doses, with maximum daily doses several grams, adjusted by the doctor.FDA Access Data+4FDA Access Data+4FDA Access Data+4
Mechanism: Modulates calcium channels to reduce overactive pain signaling.
Common side effects: Sleepiness, dizziness, swelling of legs, weight gain, sometimes mood changes.Pregabalin (Lyrica, Lyrica CR)
Class: Antiepileptic / neuropathic pain medicine.
Use: FDA-approved for neuropathic pain and widely used to treat nerve pain in many conditions.
Typical dosing: Often starts at 150 mg per day split into 2–3 doses, increased up to about 300–600 mg/day if needed.FDA Access Data+5FDA Access Data+5FDA Access Data+5
Mechanism: Binds to calcium channel subunits and reduces abnormal release of pain neurotransmitters.
Side effects: Dizziness, sleepiness, weight gain, swelling, blurry vision.Duloxetine (Cymbalta)
Class: Serotonin–norepinephrine reuptake inhibitor (SNRI) antidepressant.
Use: FDA-approved for diabetic neuropathic pain and fibromyalgia; sometimes used to help neuropathic pain in CMT.FDA Access Data+2FDA Access Data+2
Typical dosing: Adults usually start at 30–60 mg once daily, adjusted by the doctor.
Mechanism: Increases serotonin and norepinephrine in pain pathways in the brain and spinal cord, which dampens pain signals.
Side effects: Nausea, dry mouth, sleepiness or insomnia, sweating, raised blood pressure in some people.Amitriptyline
Class: Tricyclic antidepressant.
Use: Low doses are often used for chronic neuropathic pain, especially at night.
Typical dosing: Commonly starts around 10–25 mg at bedtime and may be slowly increased.FDA Access Data+2FDA Access Data+2
Mechanism: Blocks reuptake of serotonin and norepinephrine and also affects pain-modulating receptors.
Side effects: Dry mouth, constipation, sleepiness, weight gain, and risk of heart rhythm changes at higher doses.Nortriptyline
Class: Tricyclic antidepressant.
Use: Similar to amitriptyline but sometimes better tolerated in terms of drowsiness and side effects.
Dosing: Low bedtime dose, slowly increased as needed under supervision.
Mechanism: Enhances descending pain-inhibiting pathways in the spinal cord.
Side effects: Dry mouth, dizziness, constipation, and possible heart rhythm effects.Venlafaxine
Class: SNRI antidepressant.
Use: Sometimes used off-label for neuropathic pain and for mood symptoms in chronic illness.
Dosing: Usually starts at a low dose once daily, then adjusted.
Mechanism: Boosts norepinephrine and serotonin to modify pain perception and improve mood.
Side effects: Nausea, sweating, raised blood pressure, insomnia.Carbamazepine
Class: Antiepileptic drug.
Use: Used for some nerve pain syndromes; occasionally tried in severe neuropathic pain in CMT.
Mechanism: Stabilizes sodium channels in overactive nerve cells to reduce firing.
Side effects: Drowsiness, dizziness, low sodium, and rare serious blood or liver problems.Oxcarbazepine
Class: Antiepileptic drug.
Use: Alternative to carbamazepine for nerve pain in some patients.
Mechanism: Similar sodium channel effects that calm abnormal nerve activity.
Side effects: Dizziness, double vision, low sodium, allergic reactions.Topiramate
Class: Antiepileptic.
Use: Sometimes used when other neuropathic pain meds fail, or if there is migraine as well.
Mechanism: Affects several channels and receptors to reduce nerve excitability.
Side effects: Tingling in hands/feet, weight loss, cognitive slowing, kidney stones.Tramadol
Class: Weak opioid + SNRI-like analgesic.
Use: Short-term treatment of moderate neuropathic or musculoskeletal pain when other options fail.
Mechanism: Acts on opioid receptors and blocks reuptake of norepinephrine and serotonin.
Side effects: Nausea, dizziness, constipation, risk of dependence and serotonin syndrome with other drugs.Naproxen or other NSAIDs
Class: Non-steroidal anti-inflammatory drugs.
Use: For muscle, joint, and overuse pain, not specifically for nerve pain.
Mechanism: Block COX enzymes and reduce inflammatory chemicals around joints and strained muscles.
Side effects: Stomach irritation, kidney strain, and bleeding risk if used long term.Acetaminophen (paracetamol)
Class: Analgesic and antipyretic.
Use: Mild to moderate pain and fever.
Mechanism: Acts mainly in the central nervous system to reduce pain perception.
Side effects: Liver damage if total daily dose is too high or taken with alcohol.Baclofen
Class: Muscle relaxant.
Use: For muscle stiffness or spasms that can sometimes appear with chronic neuropathy.
Mechanism: Activates GABA-B receptors in the spinal cord to reduce muscle tone.
Side effects: Sleepiness, weakness, dizziness, withdrawal symptoms if suddenly stopped.Tizanidine
Class: Alpha-2 adrenergic agonist muscle relaxant.
Use: Treats muscle spasticity or cramps.
Mechanism: Reduces excitatory neurotransmitters to motor neurons, lowering muscle tone.
Side effects: Sleepiness, low blood pressure, dry mouth, liver enzyme elevations.Botulinum toxin injections
Class: Neurotoxin (local injection).
Use: In selected cases, to relax overactive muscles causing deformity or pain.
Mechanism: Temporarily blocks acetylcholine release at the neuromuscular junction, relaxing muscles.
Side effects: Local weakness, injection-site pain, rare spread of toxin effects.Short-term benzodiazepines (for severe anxiety or muscle spasm)
Class: Anxiolytic / muscle relaxant.
Use: For short periods in crisis situations such as severe anxiety related to disease progression.
Mechanism: Enhance GABA to calm the central nervous system.
Side effects: Sedation, dependence, memory problems, falls in weak patients.Selective serotonin reuptake inhibitors (SSRIs)
Class: Antidepressants.
Use: To manage depression or anxiety, which are common in chronic neurological disease.
Mechanism: Increase serotonin levels over weeks, improving mood and coping.
Side effects: Nausea, sleep changes, sexual side effects, rare bleeding risk.Vitamin D (prescription strength if deficient)
Class: Hormone-like vitamin supplement.
Use: To correct deficiency and support bone health when mobility is reduced.
Mechanism: Regulates calcium balance and bone mineralization.
Side effects: High doses can cause high calcium, nausea, kidney problems.Bisphosphonates (if severe bone loss)
Class: Bone-strengthening drugs.
Use: For osteoporosis from long-term reduced activity or steroid use.
Mechanism: Slow bone breakdown by osteoclasts, increasing bone density.
Side effects: Stomach upset, rare jaw or thigh bone problems with long use.Non-opioid sleep medicines (e.g., low-dose melatonin or specific prescription agents)
Class: Sleep aids, varied mechanisms.
Use: To improve sleep when pain and discomfort disrupt rest.
Mechanism: Either act on melatonin receptors or GABA receptors to help sleep onset.
Side effects: Daytime drowsiness, unusual dreams, or balance issues in some people.
Dietary Molecular Supplements
(Always discuss supplements with a doctor; doses here are typical adult ranges, but must be individualized.)
Vitamin B12 (methylcobalamin) – Supports myelin and nerve repair; typical oral doses range from 500–1000 mcg/day if deficient.
Folate (vitamin B9) – Helps DNA repair and nerve cell function; often 400–800 mcg/day in adults unless a higher therapeutic dose is prescribed.
Vitamin B6 (pyridoxine, with careful limits) – Needed for nerve function; if used, usually low doses (e.g., 10–25 mg/day) because very high doses over time can actually damage nerves.
Alpha-lipoic acid – An antioxidant used in diabetic neuropathy; typical doses around 300–600 mg/day in studies. It may reduce oxidative stress in nerve cells.
Omega-3 fatty acids (EPA/DHA) – From fish oil or algae; 1–2 g/day of combined EPA/DHA can support anti-inflammatory effects and heart health.
Coenzyme Q10 – Supports mitochondrial energy production in nerve cells; doses often 100–300 mg/day.
Vitamin D3 – If levels are low, doctors may prescribe 1000–2000 IU/day or higher short-term; supports bone and muscle function.
Magnesium – Helps muscle relaxation and nerve conduction; common doses are 200–400 mg elemental magnesium/day, avoiding excess in kidney disease.
Acetyl-L-carnitine – Studied in some neuropathies; doses like 500–1000 mg 1–2 times daily may support mitochondrial energy and nerve repair.
Curcumin (from turmeric) – Anti-inflammatory antioxidant; typical supplemental doses 500–1000 mg/day with piperine to improve absorption, if tolerated.
Immunity-Boosting and Regenerative / Stem-Cell-Related Approaches
At present, there are no FDA-approved stem-cell or gene-therapy drugs specifically for CMT2T. Research is active, especially in CMT in general, but treatments are still experimental and usually available only in clinical trials.CMT Research Foundation+2ResearchGate+2
Gene therapy research for CMT2 – Experimental therapies deliver a correct gene or silence a toxic one using viral vectors. In the future, this may be tailored to MME-related CMT2T, but right now it is only in early research and some clinical trials for other subtypes.
Stem cell research for peripheral neuropathy – Studies are testing stem cells to release growth factors that support damaged nerves. These approaches aim to regenerate or protect axons, but none are standard care yet for CMT2T.
Neurotrophic-factor–based drugs (research) – Scientists are testing medicines that mimic natural nerve growth factors to help survival and repair of axons. These are experimental and not routine treatment.
Immune optimization through vaccination – Simple but powerful: staying up-to-date with vaccines (like flu and pneumonia vaccines) reduces severe infections that could weaken already fragile breathing and mobility.
Adequate protein intake – Not a “drug,” but enough dietary protein gives the body the raw material to maintain muscles and repair tissues. Doctors may suggest higher protein if weight is low.
Participation in clinical trials – Some trials test new nerve-protective or genetic therapies. Joining a trial under a specialist team is the safest way to access experimental regenerative ideas. Patients can search via rare disease and CMT organizations or clinical trial registries.CMT Research Foundation+2ResearchGate+2
Surgeries (Procedures and Why They Are Done)
Foot deformity correction (osteotomy and fusion)
Surgeons may cut and realign bones in the foot, sometimes fusing joints. This is done when high arches, claw toes, or twisted feet make walking painful or unsafe. The goal is to create a flatter, more stable foot that fits better into shoes and braces.nhs.uk+1Tendon transfer surgery
A stronger tendon is moved to replace the action of a weak one, often around the ankle. This helps lift the front of the foot (foot drop) or balance the heel. It is done when bracing alone cannot maintain safe walking.Achilles tendon lengthening
When the calf tendon becomes very tight, the ankle cannot bend up properly. Lengthening the tendon under anesthesia allows the foot to sit flat in shoes and reduces contractures.Spinal stabilization surgery (for scoliosis)
If CMT-related muscle weakness leads to a curved spine, rods and screws may be placed to straighten and stabilize it. This is considered when curvature causes pain, breathing problems, or major imbalance.Feeding tube (gastrostomy) in severe swallowing problems
In advanced cases with serious swallowing difficulty and weight loss, a tube into the stomach can be placed surgically. It ensures safe nutrition and reduces risk of aspiration pneumonia.
Preventions (Mainly Preventing Complications)
You cannot prevent the genetic cause, but you can prevent many complications with early rehab and regular check-ups.
Avoid medicines that are known to be toxic to peripheral nerves (your neurologist can give a list).
Use proper footwear and braces to prevent falls and ankle sprains.
Do regular physiotherapy and stretching to prevent contractures and joint stiffness.
Keep weight in a healthy range so weak legs do not have to carry extra load.
Keep vaccinations up to date to reduce serious lung infections.
Treat infections (especially chest infections) early to protect breathing.
Make the home environment safe: remove loose rugs, improve lighting, and add grab bars.
Have regular neurologist reviews to catch new problems with breathing, swallowing, or severe pain.
Offer genetic counseling for family members so future pregnancies can be planned with full information.
When to See Doctors
People with CMT2T should have routine follow-ups with a neurologist, physiotherapist, and sometimes a rehabilitation specialist even when they feel stable. You should seek medical help quickly if:
you notice new or rapidly worsening weakness, especially in legs, hands, or face
you start having trouble walking, frequent falls, or cannot climb stairs like before
you develop shortness of breath at rest, while talking, or when lying flat, or wake up short of breath
swallowing becomes hard, you choke on food or drink, or your voice changes
pain suddenly becomes severe, burning, or unmanageable with your usual plan
you notice major changes in mood, such as strong anxiety, hopelessness, or thoughts that worry you
there are serious medication side effects such as rash, swelling of face or tongue, yellow eyes, very dark urine, or severe dizziness
If any of these happen, it is important to see a doctor or go to emergency care, depending on how urgent it feels.Mayo Clinic+1
Things to Eat and Things to Avoid
Helpful foods (what to eat):
Lean proteins like fish, eggs, lentils, and poultry to support muscles.
Whole grains (brown rice, oats) for steady energy instead of sugar spikes.
Colorful fruits and vegetables for antioxidants and vitamins that fight oxidative stress.
Fatty fish (salmon, sardines) or plant omega-3 sources for anti-inflammatory effects.
Nuts and seeds (almonds, walnuts, flaxseed) in small handfuls for healthy fats.
Low-fat dairy or fortified alternatives for calcium and vitamin D.
High-fiber foods (beans, vegetables, whole grains) to prevent constipation from some medicines.
Plenty of water to stay hydrated and help with muscle and joint function.
Herbs and spices (turmeric, ginger, garlic) for extra anti-inflammatory support in cooking.
Small, regular meals if fatigue is worse after large meals.
Things to limit or avoid:
Excess alcohol, which can damage nerves and interact with medicines.
High-sugar drinks and sweets that cause weight gain and energy crashes.
Very salty processed foods, which can worsen swelling or blood pressure issues.
Deep-fried fast foods, which add unhealthy fats and increase inflammation.
Large doses of vitamin B6 taken without medical supervision, because they can harm nerves.
Energy drinks with high caffeine and sugar, which can disturb sleep and heart rhythm.
Crash diets that cause rapid weight loss and muscle wasting.
Very high-protein “body-building” supplements without doctor advice, especially with kidney problems.
Grapefruit juice with certain medicines if your doctor or pharmacist warns about interactions.
Any herbal supplement marketed as a “miracle cure for neuropathy” without good evidence or doctor review.
Frequently Asked Questions (FAQs)
Is CMT2T curable?
No. Right now CMT2T cannot be cured. Treatment aims to slow problems, support function, and manage pain and complications.Can CMT2T shorten life?
Many people have a normal life span, especially if breathing and swallowing are monitored and treated early. Severe cases with respiratory involvement may have higher risks, so follow-up is very important.GARD Information Center+1Is CMT2T the same as other CMT types?
It shares many symptoms, like distal weakness and sensory loss, but the genetic cause (often in the MME gene) and some details of onset and severity are different. That is why genetic testing is helpful.Will exercise make my nerves worse?
Gentle, well-planned exercise supervised by physiotherapists is usually safe and helpful. Over-exercising to exhaustion can increase fatigue and pain, so programs should be moderate and tailored.PMC+1Can children inherit CMT2T from me?
Yes. Because it is usually autosomal recessive, both parents being carriers gives a 25% chance that each child will be affected, 50% chance to be a carrier, and 25% chance to be unaffected. A genetic counselor can explain your specific risk.GARD Information Center+1Why do I need braces or orthotics?
Braces help control foot drop and ankle instability. They can make walking safer and less tiring and delay deformities. Many people find they can walk farther and more confidently with the correct brace.Do I have to use a wheelchair?
Not always. Some people need a wheelchair only for long distances or later in the disease. Using a wheelchair when needed is not a failure; it is a tool to save energy and prevent falls.Can pain always be controlled?
Pain can usually be reduced but may not disappear completely. A combination of medicines, physiotherapy, and self-management strategies often works better than any one method alone.Are “nerve repair supplements” enough by themselves?
No. Supplements may support general nerve health but cannot replace physiotherapy, orthotics, good medical care, or disease-specific research treatments.Is surgery always needed for foot deformities?
No. Many people manage with braces and good shoes. Surgery is considered when deformity is severe, painful, or stops braces from working well.Can CMT2T affect my lungs?
In some advanced cases, the muscles that help you breathe can weaken, leading to shortness of breath or nighttime breathing problems. Regular monitoring and early respiratory support can help a lot.GARD Information Center+1Will CMT2T affect my mind or intelligence?
CMT mainly affects peripheral nerves. It does not directly damage memory or intelligence. Emotional health, however, can be affected by living with a long-term condition, so mental health support is important.Is gene therapy available for me now?
Not yet for CMT2T. Some CMT types are already in early gene-therapy trials, and research is moving quickly, but it is still experimental. Staying linked with specialist centers and patient groups will help you hear about new trials.CMT Research Foundation+1Should my family members be tested?
This is a personal decision. Genetic counseling can help relatives understand risks, benefits, and what test results might mean for them and for future children.What is the most important thing I can do right now?
The most important steps are: stay connected with a neurologist experienced in CMT, start or continue physiotherapy and safe exercise, protect your feet and balance, manage pain with professional guidance, and look after your emotional wellbeing.
Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.
The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members
Last Updated: December 22, 2025.
